Zimmer Biomet Updates 2018 Revenue Guidance – Quick Facts

Zimmer Biomet Holdings, Inc. (ZBH) announced, for the full year, the company now expects revenue growth to be in a range of 1.0% to 2.5% compared to the prior year, including the positive contribution of between 100 and 150 basis points of foreign currency translation. Additionally, the company now expects full-year free cash flow to be in a range of $1.2 billion to $1.35 billion. All other prior guidance for 2018 remains unchanged.

Second quarter adjusted diluted earnings per share were $1.92, a decrease of 7.7% from the prior year period. Net sales were $2.008 billion, an increase of 3.0% over the prior year period, and an increase of 1.0% on a constant currency basis.

by RTTNews Staff Writer

Source: Read Full Article